Good rate of clinical response to cholinesterase inhibitors in mild and moderate Alzheimer's disease after three months of treatment: An open-label study

Life expectancy in Brazil has increased markedly over the last 30 years. Hence, age-related disorders, such as Alzheimer's disease (AD), warrant special attention due to their high prevalence in the elderly. Pharmacologic treatment of AD is based on cholinesterase inhibitors (ChEI) and memantin...

Descripción completa

Detalles Bibliográficos
Autores principales: de Miranda, Luis Felipe José Ravic, Barbosa, Marilourdes do Amaral, Peles, Patrícia Regina Henrique, Pôças, Patrícia Hilar, Tito, Pedro Augusto Lopes, Matoso, Rafael de Oliveira, de Lima, Thiago Oliveira Lemos, de Moraes, Edgar Nunes, Caramelli, Paulo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação de Neurologia Cognitiva e do Comportamento 2013
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5619517/
https://www.ncbi.nlm.nih.gov/pubmed/29213839
http://dx.doi.org/10.1590/S1980-57642013DN70200009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5619517/
https://www.ncbi.nlm.nih.gov/pubmed/29213839
http://dx.doi.org/10.1590/S1980-57642013DN70200009

Ejemplares similares